Interventional antimicrobial therapy in febrile neutropenic patients

Autor: Wolfgang Hiddemann, Hartmut Link, W. Stille, M. Helmerking, Georg Maschmeyer, Dieter Adam, P. Meyer

Publikováno v: Annals of Hematology. 69:231-243

In this prospective multicenter trial, treatment strategies for 1573 patients with neutropenia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d0d7092454c6436736623bfc1233ad9
https://doi.org/10.1007/bf01700277

Cytostatic Anticancer Drug Development: Preclinical Studies and Early Clinical Trials

Autor: H. Ludwig, K. Havemann, K. Pollow, B. Kornhuber, G. Maschmeyer, M.E. Heim, H. Deicher, W. Hiddemann, H. Wilke, L. Hoffmann, F. Overkamp, K. Lennert, R. Waldmann, M.v. Bülow, H. Gisslinger, H. Köppler, W. Bätz, H. Stein, A. Grothey, E. Fritz, U. Cammerer, M. Fritz, H. Flechtner, J. Stirbu, S. Kunz, D.K. Hossfeld, L. Edler, G.v. Ingersleben, D. Schmähl, C. Gropp, S. Verhees, W. Queißer, M.R. Berger, E. Busse, R. Herrmann, J. Selbach, P. Drings, S. Oehl, H. Konyar, U. Bruntsch, D. Hossfeld, I.-M. v. Broen, R. Holle, V. Cour, H. Link, D. Adam, F. Trux, A. Sinop, H. Kuhn, W. Zeller, E.U. Steinhauer, E. Neeser, B. Steinke, P. Unterburger, K. Schumacher, J.P. Obrecht, B. Mentges, P. Preusser, H. Langenbahn, R. Coldewey, M. Fink, A. Ganser, E. Lötzke, J. Hartlapp, R. Pfab, K. Höffken, M. Flasshove, M. Helmerking, H. J. Schmoll, D. Peest, W. Noder, H. Kotzmann, D. Hoelzer, H.O. Klein, E.D. Kreuser, H.H. Goßmann, H.J. Weh, H.-J. Grill, H. Ehrhart, R. Hein, K.H. Pflüger, C.N. Gutt, E. Heidemann, I. Eschenbach, K. Possinger, P. Meyer

Publikováno v: Oncology Research and Treatment. 13:57-60

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2a3331db1962955371764c52860abd3c
https://doi.org/10.1159/000216722

[Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis]

Autor: D, Adam, H, Scholz, M, Helmerking

Publikováno v: Fortschritte der Medizin. Originalien. 119

Group A Streptococci have remained sensitive to penicillins and other betalactam antibiotics, e. g. cephalosporins. Since the beginning of the 1950s oral penicillin V given three times daily in a dose of 50,000 IU daily has been the drug of choice ag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dbef8dced739f9ec5be9d91cc9ac387f
https://pubmed.ncbi.nlm.nih.gov/15704358

Empirical Antimicrobial Therapy of FUO and Proved Infections in Neutropenic Patients

Autor: M. Helmerking, D. Adam, M. Wilhelm, Dieter Buchheidt, B. Glass, Hartmut Link, W. Hiddemann, O. A. Cornely, G. Maschmeyer

Publikováno v: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ISBN: 9783642621093

Infections in neutropenic patients still represent a great challenge since they often lack other signs of infection except fever, and infection rapidly can become fatal if not treated appropriately. Empirical treatment of those patients has already b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1f6caf37dfcf9d7d0cd27136f1620e6b
https://doi.org/10.1007/978-3-642-18156-6_53

[Therapy of infections in patients with acute leukemia]

Autor: W, Hiddemann, G, Maschmeyer, H, Link, M, Helmerking, D, Adam

Publikováno v: Medizinische Klinik (Munich, Germany : 1983). 92(7)

Infections are the major cause for treatment failure in acute leukemias. They mostly present as fever of unknown origin (FUO), a smaller but prognostically unfavorable group are pneumonias. The effective management of infectious complications require

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::62a1601c501b38e1d6225944fe486b0b
https://pubmed.ncbi.nlm.nih.gov/9324625